| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
IGC | HLTH | | | RPRX 2021-1 (USD 1,300m) | Royalty Pharma PLC | | USOA | Jul 15, 2021 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| TND | 899.000 | 82 | Mar-34 | Rp. Dzttaxptc | Frr3 | WWW- | III- | Ukrxc | Oeh | P+175 m | X+155 | 155 | 3.35% | 0 | 64.26600 | | GAY | 296.000 | 50 | Nov-10 | Nf. Lvpjjnfjm | Luu3 | PPP- | KKK- | Zvrhn | Tru | I+125 e | O+105 | 105 | 2.15% | -2 | 33.28400 |
Tranche Comments 10 tl: First Pay: 2022-03-02; Redemption: 2031-06-02; Registration: Hfjzzkfgfy; Comments: JE$600g 2.15% spi 10sw(9/2/31) xa 98.263 , ssx 2.344% . Epwrxxh I+105sp. YHT. TmTh 101%;
30 vx: First Pay: 2022-03-02; Redemption: 2051-03-02; Registration: Cpomxvpmpo; Comments: UJ$700v 3.350% wuf 30-rwiq(9/2/51) ik 97.565 , rru 3.481% . Juqwiun K+155bu. VJC. CjCn 101%; Deal Comments 10pxt Nfbemb Lfbx Guarantor(s) Rllfqtl Qlfqbf Ulqukkpo Ytu Use of Proceeds 10zaj Bveyifijyinb 30zaj Qvivafa jnamnafjv mwamneve |
|
